.

Make Better Decisions

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Julphar
Teva
Moodys
Dow
Colorcon
Covington
Novartis
Express Scripts
Chubb
Citi

Generated: December 15, 2017

DrugPatentWatch Database Preview

Ioversol - Generic Drug Details

« Back to Dashboard

What are the generic sources for ioversol and what is the scope of ioversol patent protection?

Ioversol
is the generic ingredient in five branded drugs marketed by Liebel-flarsheim and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are two drug master file entries for ioversol. One supplier is listed for this compound.

Pharmacology for ioversol

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Liebel-flarsheimOPTIRAY 350ioversolINJECTABLE;INJECTION019710-005Jan 22, 1992RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Liebel-flarsheimOPTIRAY 160ioversolINJECTABLE;INJECTION019710-003Dec 30, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Liebel-flarsheimOPTIRAY 320ioversolINJECTABLE;INJECTION020923-002May 29, 1998RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Liebel-flarsheimOPTIRAY 240ioversolINJECTABLE;INJECTION020923-001May 28, 1998DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Liebel-flarsheimOPTIRAY 300ioversolINJECTABLE;INJECTION020923-004May 13, 1999RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Liebel-flarsheimOPTIRAY 320ioversolINJECTABLE;INJECTION019710-001Dec 30, 1988RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Liebel-flarsheimOPTIRAY 350ioversolINJECTABLE;INJECTION020923-003May 28, 1998RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Liebel-flarsheimOPTIRAY 240ioversolINJECTABLE;INJECTION019710-002Dec 30, 1988RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Liebel-flarsheimOPTIRAY 300ioversolINJECTABLE;INJECTION019710-004Jan 22, 1992RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: ioversol

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Liebel-flarsheimOPTIRAY 350ioversolINJECTABLE;INJECTION019710-005Jan 22, 1992► Subscribe► Subscribe
Liebel-flarsheimOPTIRAY 160ioversolINJECTABLE;INJECTION019710-003Dec 30, 1988► Subscribe► Subscribe
Liebel-flarsheimOPTIRAY 350ioversolINJECTABLE;INJECTION020923-003May 28, 1998► Subscribe► Subscribe
Liebel-flarsheimOPTIRAY 320ioversolINJECTABLE;INJECTION020923-002May 29, 1998► Subscribe► Subscribe
Liebel-flarsheimOPTIRAY 300ioversolINJECTABLE;INJECTION019710-004Jan 22, 1992► Subscribe► Subscribe
Liebel-flarsheimOPTIRAY 320ioversolINJECTABLE;INJECTION019710-001Dec 30, 1988► Subscribe► Subscribe
Liebel-flarsheimOPTIRAY 240ioversolINJECTABLE;INJECTION020923-001May 28, 1998► Subscribe► Subscribe
Liebel-flarsheimOPTIRAY 240ioversolINJECTABLE;INJECTION019710-002Dec 30, 1988► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
QuintilesIMS
Moodys
Daiichi Sankyo
Julphar
Citi
Queensland Health
Baxter
Teva
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot